Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.2 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |